eTheRNA raised €39M in a Series B round in Aug 2022. The company is based in Jette, Belgium. Investors in the round: FundPlus, Grand Pharma, LSP and 4 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €39M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
